Innovation1 Biotech Inc.
IVBT · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $156 | $137 | $18 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $56 | $0 | $133 |
| Inventory | $0 | -$56 | $17 | $37 |
| Other Curr. Assets | $15 | $130 | $14 | $14 |
| Total Curr. Assets | $73 | $287 | $168 | $202 |
| Property Plant & Equip (Net) | $2 | $485 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $42,982 | $2 | $2 |
| Long-Term Investments | $0 | $0 | $11 | $3 |
| Tax Assets | $0 | $0 | -$13 | -$6 |
| Other NC Assets | $0 | $210 | $13 | $6 |
| Total NC Assets | $3 | $43,676 | $13 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $76 | $43,963 | $182 | $209 |
| Liabilities | – | – | – | – |
| Payables | $349 | $109 | $42 | $443 |
| Short-Term Debt | $10 | $209 | $160 | $841 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $994 | $0 | $147 |
| Other Curr. Liab. | $2,928 | $28,500 | $205 | $1,454 |
| Total Curr. Liab. | $3,287 | $29,812 | $407 | $2,887 |
| LT Debt | $219 | $298 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $11,000 | $0 | $0 |
| Total NC Liab. | $219 | $11,298 | $204 | $1,285 |
| Other Liabilities | $0 | $0 | -$204 | -$1,285 |
| Cap. Leases | $0 | $498 | $0 | $0 |
| Total Liabilities | $3,506 | $41,111 | $407 | $2,887 |
| Equity | – | – | – | – |
| Pref Stock | $8 | $8 | $3 | $8 |
| Common Stock | $20 | $20 | $0 | $58 |
| Retained Earnings | -$58,630 | -$44,551 | -$2,974 | -$3,844 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $55,172 | $47,376 | $2,746 | $1,100 |
| Total Equity | -$3,430 | $2,853 | -$225 | -$2,678 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $76 | $43,963 | $182 | $209 |
| Net Debt | $179 | $351 | $23 | $823 |